Outpatient narcotic consumption following total shoulder arthroplasty

Alexander Martusiewicz, Adam Z Khan, Aaron M Chamberlain, Jay D Keener, Alexander W Aleem, Alexander Martusiewicz, Adam Z Khan, Aaron M Chamberlain, Jay D Keener, Alexander W Aleem

Abstract

Introduction: In the setting of the opioid epidemic, physicians continue to scrutinize ways to minimize exposure to narcotic medications. Several studies emphasize improvements in perioperative pain management following total shoulder arthroplasty (TSA). However, there is a paucity of literature describing outpatient narcotic consumption requirements following TSA.

Methods: A single-institution, prospective study of patients undergoing primary TSA was performed. Preoperative demographics including exposure to narcotics, smoking history, and alcohol exposure were collected. The primary outcome was measurement of total outpatient narcotic consumption 6 weeks from surgery. Narcotic consumption was verified by counting leftover pills at the final follow-up visit.

Results: Overall, 50 patients were enrolled. The median narcotic consumption in the cohort was 193 morphine equivalent units (MEUs), approximately 25 (5-mg) tablets of oxycodone, and the mean consumption was 246 MEUs, approximately 32 (5-mg) tablets. Almost 25% of patients consumed fewer than 10 total tablets, with 10% of patients taking no narcotics at home. Multivariate regression found preoperative narcotic exposure associated with increased consumption of 31 MEUs (P = .004). Older age was found to be protective of narcotic consumption, with increasing age by 1 year associated with 0.75 MEU decrease in consumption (P = .04).

Conclusions: Anatomic total shoulder arthroplasty in general provides quick, reliable pain relief and does not require a significant amount of narcotic medication postoperatively. For most patients, it is reasonable to prescribe the equivalent of 25-30 (5-mg) oxycodone tablets following TSA.

Keywords: Shoulder arthroplasty; narcotic; opioid; opioid epidemic; outpatient pain management; shoulder arthritis.

© 2019 The Authors.

Figures

Figure 1
Figure 1
Distribution of total narcotic consumption at 2 weeks postoperation. MEUs, morphine equivalent units.
Figure 2
Figure 2
Distribution of total narcotic consumption at 6 weeks postoperation. MEUs, morphine equivalent units.

References

    1. Baidya D.K., Agarwal A., Khanna P.K., Arora M. Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol. 2011;27:307–314.
    1. Boddu C., Genza A., McCann P.D. Bridging multimodal pain management provides 48-hour pain control in patients undergoing total shoulder replacement. J Shoulder Elbow Surg. 2018;27:S65–S69.
    1. Centers for Disease Control and Prevention (CDC) CDC grand rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10–13.
    1. Cheah J.W., Sing D.C., McLaughlin D., Feeley B.T., Ma C.B., Zhang A.L. The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes. J Shoulder Elbow Surg. 2017;26:1908–1914.
    1. Codding J.L., Getz C.L. Pain management strategies in shoulder arthroplasty. Orthop Clin North Am. 2018;49:81–91.
    1. Dowell D., Haegerich T.M., Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624–1645.
    1. Hill M.V., McMahon M.L., Stucke R.S., Barth R.J., Jr. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265:709–714.
    1. Kahn C.B. Trends in opioid analgesic abuse and mortality in the United States. J Emerg Med. 2015;48:525–526.
    1. Kim N., Matzon J.L., Abboudi J., Jones C., Kirkpatrick W., Leinberry C.F. A prospective evaluation of opioid utilization after upper-extremity surgical procedures. J Bone Joint Surg. 2016;98:e89.
    1. Kolodny A., Courtwright D., Hwang C.S., Kreiner P., Eadie J.L., Clark T. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574.
    1. Kumar K., Gulotta L.V., Dines J.S., Allen A.A., Cheng J., Fields K.G. Unused opioid pills after outpatient shoulder surgeries given current perioperative prescribing habits. Am J Sports Med. 2017;45:636–641.
    1. Leas D.P., Connor P.M., Schiffern S.C., D'Alessandro D.F., Roberts K.M., Hamid N. Opioid-free shoulder arthroplasty: a prospective study of a novel clinical care pathway. J Shoulder Elbow Surg. 2019;28:1716–1722.
    1. Levy B., Paulozzi L., Mack K.A., Jones C.M. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med. 2015;49:409–413.
    1. Lin J., Zhang L., Yang H. Perioperative administration of selective cyclooxygenase-2 inhibitors for postoperative pain management in patients after total knee arthroplasty. J Arthroplasty. 2013;28:207–213.e2.
    1. Menendez M.E., Lawler S.M., Ring D., Jawa A. High pain intensity after total shoulder arthroplasty. J Shoulder Elbow Surg. 2018;27:2113–2119.
    1. Menendez M.E., Ring D., Bateman B.T. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res. 2015;473:2402–2412.
    1. Nicholson T., Maltenfort M., Getz C., Lazarus M., Williams G., Namdari S. Multimodal pain management protocol versus patient controlled narcotic analgesia for postoperative pain control after shoulder arthroplasty. Arch Bone Jt Surg. 2018;6:196–202.
    1. Rodgers J., Cunningham K., Fitzgerald K., Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg Am. 2012;37:645–650.
    1. Rubenstein W., Grace T., Croci R., Ward D. The interaction of depression and prior opioid use on pain and opioid requirements after total joint arthroplasty. Arthroplast Today. 2018;4:464–469.
    1. Sabatino M.J., Kunkel S.T., Ramkumar D.B., Keeney B.J., Jevsevar D.S. Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J Bone Joint Surg. 2018;100:180–188.
    1. Syed U.A.M., Aleem A.W., Wowkanech C., Weekes D., Freedman M., Tjoumakaris F. Neer Award 2018: The effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized clinical trial. J Shoulder Elbow Surg. 2018;27:962–967.
    1. Welton K.L., Kraeutler M.J., McCarty E.C., Vidal A.F., Bravman J.T. Current pain prescribing habits for common shoulder operations: a survey of the American Shoulder and Elbow Surgeons membership. J Shoulder Elbow Surg. 2018;27:S76–S81.
    1. Westermann R.W., Anthony C.A., Bedard N., Glass N., Bollier M., Hettrich C.M. Opioid consumption after rotator cuff repair. Arthroscopy. 2017;33:1467–1472.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere